Expertise and rankings

  • Cutting-edge research. Scientists at Mayo Clinic are investigating new treatments for systemic mastocytosis. As a Mayo Clinic patient, you may have access to the latest treatment trials.
  • Personalized care. At Mayo Clinic, doctors manage systemic mastocytosis by regularly monitoring your condition, then tailoring a treatment plan to help you manage your specific symptoms.
  • Nationally recognized expertise. Mastocytosis is a rare condition. It's estimated to affect only 1 in 10,000 people. Mayo Clinic doctors have experience diagnosing and caring for people with systemic mastocytosis, and see nearly 70 people with the disorder each year.
July 11, 2017
References
  1. Pardanani A. Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management. American Journal of Hematology. 2016;91:1146.
  2. Mastocytosis. Genetic and Rare Disease Information Center. https://rarediseases.info.nih.gov/diseases/6987/mastocytosis. Accessed Feb. 20, 2017.
  3. Castells MC. Mastocytosis (cutaneous and systemic): Epidemiology, pathogenesis, and clinical manifestations. http://www.uptodate.com/home. Accessed Feb. 19, 2017.
  4. AskMayoExpert. Systemic mastocytosis. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2016.
  5. Brown AY. Allscripts EPSi. Mayo Clinic, Rochester, Minn. Jan. 25, 2017.
  6. Akin C, et al. Systemic mastocytosis: Management and prognosis. http://www.uptodate.com/home. Accessed Feb. 19, 2017.
  7. Pardanani A. Systemic mastocytosis: Evolving lessons from large patient registry datasets. American Journal of Hematology. 2016;91:654.